Use of CA 125 in follow-up of ovarian cancer.
Rustin
G
G
Tuxen
M
M
D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen